{
    "clinical_study": {
        "@rank": "18486", 
        "arm_group": [
            {
                "arm_group_label": "dexmetomedine group", 
                "arm_group_type": "Active Comparator", 
                "description": "dexmetomedine group will receive pre-delivery bilateral TAP block with 10 ml of bupivacaine 0.5 % mixed with 10 ml saline and 10 \u03bcg dexmetonedine in 20 ml syringe labeled G 2."
            }, 
            {
                "arm_group_label": "Bupivacaine  group", 
                "arm_group_type": "Active Comparator", 
                "description": "Bupivacaine  group will receive post-delivery bilateral TAP block with 10 ml of bupivacaine 0.5 % mixed with 10 ml saline in 20 ml syringe labeled G 2."
            }
        ], 
        "brief_summary": {
            "textblock": "In this study, the investigators will compare the analgesic effect of bupivacaine and\n      bupivacaine-dexmetomedine after elective cesarean delivery by performing an bilateral TAP\n      block, on the patients for whom the operation will be performed under general anesthesia."
        }, 
        "brief_title": "Transverse Abdominal Block for Analgesia in Casarean Section", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Analgesia Disorder", 
        "detailed_description": {
            "textblock": "The investigators will study 60 ASA [American Society of Anesthesiologist] physical status I\n      and \u0406\u0406 patients undergoing elective cesarean delivery at tanta University Hospital, in a\n      prospective, randomized, comparative, clinical trial.\n\n      Patients will be randomly allocated to two equal groups (n = 30) using closed envelopes\n      labeled 1,and 2 reflecting group 1and 2 respectively.\n\n      The drugs are prepared by the anesthesiologist who is not involved in the study or data\n      collection.\n\n      Group I: (n=30) will receive pre-delivery bilateral TAP block with 10 ml of bupivacaine 0.5\n      % mixed with 10 ml saline and 10 \u03bcg dexmetonedine in 20 ml syringe labeled G 2.\n\n      Group II: (n=30) will receive post-delivery bilateral TAP block with 10 ml of bupivacaine\n      0.5 % mixed with 10 ml saline in 20 ml syringe labeled G2."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. We will study 60 ASA [American Society of Anesthesiologist] physical status I and \u0406\u0406\n             patients undergoing elective cesarean delivery\n\n          2. Age between 21-40 years old.\n\n        Exclusion Criteria:\n\n          1. Refusal of participation in the study\n\n          2. Patients who have infection or tumor at the site of puncture for local anesthetic\n             injection.\n\n          3. Patients who have coagulopathy, platelet abnormalities, and concurrent treatment with\n             anticoagulant drugs.\n\n          4. Patients known to have allergy or sensitivity to dexmetomedine, and/or bupivacaine\n\n          5. Severe hepatic and/or renal insufficiency\n\n          6. Morbid obesity (body mass index (BMI) >35)\n\n          7. Psychological disease"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 22, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02122510", 
            "org_study_id": "1004/02/12"
        }, 
        "intervention": [
            {
                "arm_group_label": "Bupivacaine  group", 
                "description": "Bupivacaine group(n=30) will receive post-delivery bilateral TAP block with 10 ml of bupivacaine 0.5 % mixed with 10 ml saline and 10 \u03bcg dexmetonedine in 20 ml syringe", 
                "intervention_name": "Bupivacine group", 
                "intervention_type": "Drug", 
                "other_name": "Bucaine"
            }, 
            {
                "arm_group_label": "dexmetomedine group", 
                "description": "Dexamedtomedine group will receive post-delivery bilateral TAP block with 10 ml of bupivacaine 0.5 % mixed with 10 ml saline and 10 \u03bcg dexmetonedine in 20 ml syringe", 
                "intervention_name": "Dexmedetomidine", 
                "intervention_type": "Drug", 
                "other_name": "precdex"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Bupivacaine", 
                "Dexmedetomidine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Analgesia, casarean section, TAP block", 
        "lastchanged_date": "April 23, 2014", 
        "location": {
            "contact": {
                "email": "ayman.yousef@rocketmail.com", 
                "last_name": "Ayman A Yousef, MD", 
                "phone": "00201003497767"
            }, 
            "contact_backup": {
                "email": "ayman.yousef@rocketmail.com", 
                "last_name": "Ayman A Yousef, MD", 
                "phone": "002001003497767"
            }, 
            "facility": {
                "address": {
                    "city": "Tanta", 
                    "country": "Egypt", 
                    "state": "Algharbiya", 
                    "zip": "355217"
                }, 
                "name": "Tanta University Hospitals"
            }, 
            "investigator": {
                "last_name": "Amira A Mahfouz, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Value of Preemptive Dexmedetomidine Transversus Abdominis Plane (TAP) Block in Patients Undergoing Elective Cesarean Section Under General Anesthesia.", 
        "overall_contact": {
            "email": "ayman.yousef@rocketmail.com", 
            "last_name": "Ayman A Yousef, MD", 
            "phone": "00201003497767"
        }, 
        "overall_official": [
            {
                "affiliation": "Assistant professor", 
                "last_name": "Ayman A Yousef, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Assistant Professor", 
                "last_name": "Ayman A Yousef, MD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Egypt: Ministry of Health and Population", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "blood pressure and heart rate measured every 15 minutes during the intraopertive peroid", 
            "measure": "hemodynamic changes", 
            "safety_issue": "Yes", 
            "time_frame": "2 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02122510"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Tanta University", 
            "investigator_full_name": "Ayman Abd Al-maksoud Yousef", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "VAS will be measured during 24 hours after surgery every 4 hours", 
            "measure": "Analgesic requirements", 
            "safety_issue": "Yes", 
            "time_frame": "24 hours"
        }, 
        "source": "Tanta University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tanta University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}